Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CLPTM1 mRNA | affects expression | 21346803
|
D000965 |
Antimony |
Antimony results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D000966 |
Antimony Potassium Tartrate |
Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D002857 |
Chromium |
Chromium results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D004317 |
Doxorubicin |
CLPTM1 mRNA affects the susceptibility to Doxorubicin | affects response to substance | 16243817
|
D004958 |
Estradiol |
Estradiol results in decreased expression of CLPTM1 mRNA | decreases expression | 16705744
|
D019833 |
Genistein |
Genistein results in decreased expression of CLPTM1 mRNA | decreases expression | 16705744
|
D008628 |
Mercury |
Mercury results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D008628 |
Mercury |
Mercury results in increased expression of CLPTM1 mRNA | increases expression | 16823088
|
D008727 |
Methotrexate |
CLPTM1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C022838 |
nickel chloride |
nickel chloride results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D011192 |
Potassium Dichromate |
Potassium Dichromate results in decreased expression of CLPTM1 mRNA | decreases expression | 17547211
|
D012643 |
Selenium |
Selenium results in increased expression of CLPTM1 mRNA | increases expression | 19244175
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of CLPTM1 mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.30 | 12039119 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
10.31 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.31 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.31 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.31 | 11473722 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
3.57 | 19555203 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.58 | 21441931 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.10 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.78 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.91 | 16634805 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.76 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.84 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
2.39 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.39 | 15634643 15939500 18695136 15136595 16935488 19526202 17426702 18628466 15567936 15994142 16322301 17983394 16264153 18382427 16595493 16826403 15668708 18234424 15993339 16115903 15692762 16096432 11325840 17369602 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.39 | 12948864 17261762 17018787 14630087 16675129 19861407 18497071 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.39 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.39 | 16978400 |
MESH:D001991 |
Bronchitis |
|
Antimony |
6.20 | 8768112 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.51 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.87 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
4.04 | 19555203 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.64 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.64 | 17876044 16234567 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.64 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.17 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
5.05 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.05 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.55 | 16731534 16612575 16109756 17974986 16651473 16242529 17131338 16952015 17351982 15811867 15505089 17382496 16269455 16455267 16364871 17924179 17928571 16278810 17329180 17007740 15792986 15476868 18627295 17519947 17308081 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Antimony |
9.84 | 10334427 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
9.84 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
9.84 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.32 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.73 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.73 | 18566989 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.79 | 15894690 |
MESH:D003092 |
Colitis |
|
Selenium |
3.82 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.29 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.65 | 9562676 12039119 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.06 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.26 | 19747007 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
7.88 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
7.88 | 16823706 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.16 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.80 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.49 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.44 | 19279558 |
MESH:D004283 |
Dog Diseases |
|
Antimony |
5.71 | 12019027 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.14 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
12.14 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.14 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.14 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
12.14 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.69 | 18602426 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.64 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.62 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.62 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.62 | 11473722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.22 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
2.91 | 17016578 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.64 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.39 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.39 | 16598420 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.19 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.55 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.50 | 16244371 16879835 16144979 14766674 18674790 17875725 16707910 16244372 17888722 18006777 12587719 16495754 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.30 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.30 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.93 | 15692506 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.09 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.43 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.81 | 17088409 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.26 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.49 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.49 | 14714311 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
19.30 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
19.30 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
19.30 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
19.30 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
19.30 | 19665454 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.08 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.08 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.44 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.44 | 15610895 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.13 | 9562676 |
MESH:D007896 |
Leishmaniasis |
|
Antimony |
4.83 | 21182181 15220340 21063981 10953559 12019027 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Antimony |
4.69 | 8889330 19141829 11475954 |
MESH:D007897 |
Leishmaniasis, Mucocutaneous |
|
Antimony |
5.54 | 11370249 7854095 10651420 10881086 9643325 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony |
8.81 | 7875148 7854095 20495762 7554475 1899875 11105143 8142506 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony Potassium Tartrate |
8.81 | 12707265 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.04 | 17468513 18980019 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.22 | 16085563 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Antimony Potassium Tartrate |
4.53 | 9834237 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.71 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
5.06 | 15504291 15369754 18210741 16009107 15591649 17348192 16570917 15577212 16603200 17198567 15793283 14709902 15723089 17534399 15744066 17465448 14659978 15864749 18237412 14726149 15086199 16169303 18629640 15798949 17203207 17724770 17881167 15571005 15138612 18672772 15842777 14568256 15099470 15479170 12918455 18239293 12925901 18567088 16544323 18637143 17036385 17201889 17666798 16627068 15733078 15161499 15492853 14643895 15942678 15383259 18371158 15366600 15339415 15298665 18095165 17719030 15067225 16270385 15081153 18364076 17640959 16042886 17196135 17432682 15763062 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
5.06 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.06 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
5.06 | 17823541 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
4.43 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.85 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
4.85 | 15890375 3113478 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.10 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
10.10 | 15603536 1848544 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.10 | 17085340 16842330 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.08 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
2.85 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.85 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.99 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
7.99 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.09 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.81 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.61 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.45 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.45 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.45 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
14.45 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.55 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.29 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.32 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.32 | 15107826 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.53 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
12.69 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
12.69 | 17488658 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.01 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
6.01 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.58 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.58 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.96 | 18259882 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.78 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.81 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.02 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.89 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.89 | 16427766 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.27 | 15555623 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.46 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.27 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.12 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.13 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.93 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
4.93 | 19005980 |
MESH:D010409 |
Penile Diseases |
|
Antimony |
5.76 | 9643325 |
MESH:D010493 |
Pericarditis |
|
Antimony |
6.16 | 20465667 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.22 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.95 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.22 | 17638057 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.91 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.10 | 16868541 15897917 16729912 16888761 18437689 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.10 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.10 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.44 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
10.63 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
10.63 | 17352296 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.01 | 16767912 18313854 17203757 15675481 17710206 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.28 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.84 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.55 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
2.96 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.61 | 16767912 17203757 15625365 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.33 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
2.46 | 16033868 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.07 | 9562676 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.39 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.75 | 19048282 |
MESH:D014352 |
Trypanosomiasis |
|
Antimony |
5.99 | 15220340 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.22 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.22 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.37 | 10091137 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.26 | 17678736 17638931 17334414 16364871 |